HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > Ultroid Technologies, Inc.

Print e mail rss del Y! myWeb Tweet
 

Asian Markets Expanding for Painless Hemorrhoid Treatment

Ultroid Gets FDA Export Papers

(EMAILWIRE.COM, February 13, 2007 ) SAINT PETERSBURG, FL – Moving ahead with their plans for distributor expansion, Florida-based Ultroid Technologies, Inc. has announced the acquisition of Certificates to Foreign Governments from the U.S. Food and Drug Administration to coincide with a promotional swing through selected Asian cities by the company’s CEO.

“This is simply another step in expanding our sales base,” according to Ultroid Technologies President, Michael Cao. Speaking from Hong Kong, Cao explained, “The certificates guarantee nothing when exporting,” he said. “However, they can make the product move more quickly through busy ports like Hong Kong and Singapore by assuring those governments of the product’s authenticity.”

According to Ultroid President Gerald Spurgin, the company manufactures a painless alternative to invasive surgery. Described as a non-invasive, microelectronic device, “the machinery,” according to Spurgin, “is small enough to fit in a briefcase-sized carrier,” increasing its appeal to physicians as a mobile tool. Spurgin claims intense interest in the product has necessitated the Asian promotional swing.

The certificates list the products for export to more than 26 nations, mostly along the Pacific Rim and are verified by the US Food and Drug Administration as items marketed and legally exported from the US. Cao’s current Asian tour includes Vietnam, Singapore and Hong Kong. Ultroid’s list of distributors has recently expanded to include distributors in most Asian countries.

###
About Ultroid Technologies, Inc.:
Ultroid Technologies, Inc. (Saint Petersburg, FL) manufactures and markets the UltroidTM system for painless hemorrhoid treatment. Malpractice insurers report no need for increased premiums because of the procedure’s non-invasive nature. The non-surgical technology is a break-through in painless hemorrhoid therapy requiring no anesthesia and no patient-healing down time. Performed in the doctor’s office in minutes, patients are immediately able to resume their daily activities. UltroidTM is covered by most major insurers and Medicare.

Contact:
Ultroid Technologies, Inc.
Lee Snyder
Tel: 727-898-0717 x 23
leesnyder@ultroid.com
www.ultroid.com


Contact Information:
Ultroid Technologies, Inc.
Lee Snyder
Tel:
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:

Ultroid Gets FDA Export Papers

Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Satellite TV for PC

Watch Streaming Tv Right on Your PC

Satellitetelevisionforpc.com



 



Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012